2025-12-31 - Analysis Report
Okay, here's a comprehensive report on Chevron Corp (CVX) based on the data provided, broken down into sections with analysis:

**1) Return Rate Comparison & Alpha/Beta Analysis**

*   **Company Overview:** Chevron Corp is a multinational energy corporation involved in every facet of the oil and natural gas industries, including exploration and production; refining, marketing and transport; chemicals manufacturing and sales; and power generation.
*   **Return Rate:**
    *   CVX Cumulative Return: 36.78%
    *   VOO (S&P 500) Cumulative Return: 102.21%
    *   Divergence: -68.5 (Relative Divergence: 0.0)

*   **Analysis of Return Rate:**  Chevron has significantly underperformed the S&P 500 (VOO) over the period examined. The negative divergence of -68.5% indicates a substantial difference in returns, and the relative divergence of 0.0 suggests this is at the lower end of the historical range of divergence.

*   **Alpha/Beta Analysis Table:**

    | Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
    |------------|-------|-------|--------|------|--------|
    | 2015-2017  | 33.0% | 65.9% | 5.0%  | 0.1  | 252.2  |
    | 2016-2018  | 21.0% | 71.9% | 6.0%  | 0.2  | 219.2  |
    | 2017-2019  | 3.0%  | 71.9% | -19.0% | 0.9  | 242.8  |
    | 2018-2020  | -10.0% | 79.6% | -33.0% | 0.7  | 170.2  |
    | 2019-2021  | 22.0% | 79.6% | -25.0% | 0.6  | 236.4  |
    | 2020-2022  | 85.0% | 83.2% | 86.0%  | 0.3  | 361.6  |
    | 2021-2023  | 49.0% | 83.2% | 47.0%  | 0.4  | 300.5  |
    | 2022-2024  | -6.0% | 83.2% | -26.0% | 0.2  | 291.8  |
    | 2023-2025  | -45.0% | 74.8% | -112.0% | 0.6  | 306.9  |

*   **Analysis of Alpha/Beta Table:**
    *   **CAGR:** The Compound Annual Growth Rate fluctuates significantly.  The most recent period (2023-2025) shows a substantial decline.
    *   **MDD:**  Maximum Drawdown is consistently high, indicating significant potential for losses during downturns.
    *   **Alpha:**  Alpha, which represents the excess return compared to the market, is negative in several periods, suggesting underperformance relative to the market, especially pronounced in the most recent period.
    *   **Beta:** Beta generally ranges between 0.1 and 0.9, suggesting CVX's price is less volatile than the market as a whole (Beta=1). Periods closer to 1 indicate a higher correlation with market movements.
    *   **Cap(B):**  Market capitalization shows general growth over the analyzed time frame, reflecting the company's size.

**2) Recent Stock Price Fluctuations**

*   Close Price: 152.31
*   Last Market Data:
    *   Price: 152.31
    *   Previous Close: 150.99
    *   Change: 0.87
*   5-day SMA: 150.866
*   20-day SMA: 149.9573
*   60-day SMA: 152.1799

*   **Analysis:** The stock price is slightly above the 5-day and 20-day SMAs, which suggests a recent upward trend. It's very close to the 60-day SMA.  The small price change from the previous close indicates relatively stable recent trading.

**3) RSI, PPO, and Market Risk Indicators**

*   Market Risk Indicator (MRI): 0.9 (Medium Investment Recommended)
*   RSI: 60.74
*   PPO: 0.3029
*   Hybrid Signal: cash_0%_Buy 100% of cash (8 shares - Very Safe - MRI:0.90)
*   Recent (20 days) relative divergence change = -1.1 (-): 단기하락 (Short-term decline)
*   Expected Return (%): 763.7

*   **Analysis:**
    *   **MRI:** The MRI of 0.9 indicates a medium investment risk level, suggesting it's a relatively safe investment currently based on this indicator.
    *   **RSI:** The RSI of 60.74 suggests the stock is neither overbought nor oversold. It's trending towards overbought territory but not quite there.
    *   **PPO:** The PPO of 0.3029 suggests the shorter-term moving average is slightly above the longer-term moving average, supporting the recent upward trend seen in the SMA analysis.
    *   **Hybrid Signal:** The hybrid signal recommends buying with 100% of available cash, reinforcing the moderately positive outlook based on the MRI.
    *   **Recent Divergence Change:** The negative change in relative divergence over the past 20 days confirms a recent short-term decline.
    *   **Expected Return:** The extremely high expected return (763.7%) should be viewed with significant skepticism. Such high returns are rarely sustainable and may be based on overly optimistic assumptions.

**4) Recent News & Significant Events**

*   **Key Themes from News Headlines:**

    *   **Analyst Confidence & Dividends:** Some analysts are confident in Chevron and other dividend-paying stocks.
    *   **Institutional Investment:** Institute for Wealth Management LLC bought shares of CVX.
    *   **Catalysts & Risks:** Articles discuss oil prices, Venezuela risk (and Chevron's exceptions), and potential catalysts.
    *   **Commercial Agreements:** Chevron signed a $120M prepayment and commercial agreement with Frontera.
    *   **Venezuela Oil Shipping:** U.S. tanker seizure impacts Venezuelan oil shipping, but Chevron is an exception.

*   **Analysis:** The news is mixed. Positive aspects include analyst confidence, institutional investment, and commercial agreements.  The Venezuela situation is both a risk and potentially an opportunity for Chevron given its unique position.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~2.08)
*   **Target Price (avg/high/low):** 172.33 / 204.00 / 124.00

*   **Analysis:** Analyst consensus is generally positive (Buy), with an average target price significantly above the current price.  However, there's a wide range in target prices, indicating differing opinions on Chevron's potential.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-11-06 | 1.83 | 48.17 B$      |
| 2025-08-07 | 1.45 | 44.38 B$      |
| 2025-05-08 | 2.01 | 46.10 B$      |
| 2024-11-07 | 2.49 | 48.93 B$      |
| 2025-11-06 | 2.49 | 48.93 B$      |

*   **Analysis:** EPS and Revenue are fluctuating on a quarterly basis. Revenue has generally been in the $44B-$49B range. The most recent EPS figure is lower than some prior quarters. The earnings data does not suggest a consistent upward trend. The last row is a duplicate.

**6) Financial Information (Revenue/Profitability & Capital/ROE)**

*   **Revenue and Profitability:**

    | Quarter    | Revenue    | Profit Margin |
    |------------|------------|---------------|
    | 2025-09-30 | $48.17B    | 31.12%        |
    | 2025-06-30 | $44.38B    | 29.69%        |
    | 2025-03-31 | $46.10B    | 29.00%        |
    | 2024-12-31 | $48.33B    | 27.34%        |
    | 2024-09-30 | $48.93B    | 29.15%        |

*   **Capital and Profitability:**

    | Quarter    | Equity      | ROE    |
    |------------|-------------|--------|
    | 2025-09-30 | $189.84B    | 1.86%  |
    | 2025-06-30 | $146.42B    | 1.70%  |
    | 2025-03-31 | $149.24B    | 2.35%  |
    | 2024-12-31 | $152.32B    | 2.13%  |
    | 2024-09-30 | $156.20B    | 2.87%  |

*   **Analysis:**
    *   **Revenue:** Revenue shows some fluctuation.
    *   **Profit Margin:**  Profit margins are relatively healthy, generally around 27-31%.
    *   **Equity:** Equity has increased significantly in the most recent quarter.
    *   **ROE:** Return on Equity is relatively low, suggesting the company is not generating substantial profit relative to its equity.

**7) Comprehensive Analysis**

*   **Summary:**  Chevron's recent performance has lagged the S&P 500 significantly. While recent price action shows a slight upward trend and analyst opinions are generally positive, there are concerning signals. The high Maximum Drawdown in the alpha/beta analysis points to substantial risk. ROE is low, and recent earnings have been somewhat volatile. The extremely high "Expected Return" is highly suspect. The increase in equity should be investigated further.

*   **Overall Assessment:**  While the MRI suggests a moderate investment risk, the underperformance compared to the market, the negative alpha in recent periods, and the high MDD warrant caution. The analyst consensus and recent institutional buying provide some positive counterpoints, but a potential investor should carefully consider the risks and conduct further due diligence before investing. The high expected return should be disregarded until the source is verified and assumptions are proven realistic. The increased equity should be investigated further to determine its cause and impact.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.